Core Viewpoint - On August 18, a total of 19 listed companies had their restricted shares unlocked, with a total market value of approximately 32.581 billion yuan [1]. Group 1: Unlocking Details - The specific details of the restricted share unlocks are as follows: - **Sunshine Energy (000591)**: 314 million shares from A-share original shareholder allocation [2] - **Paislin (600215)**: 2.0375 million shares from equity incentive lock-up [2] - **Xin'ao Co. (600803)**: 253 million shares from A-share corporate allocation [2] - **Hualan Biological (301207)**: 459 million shares with extended lock-up period [2] - **Taihe New Materials (002254)**: 436,000 shares from equity incentive lock-up [2] - **Yinxi Technology (300221)**: 569,890 shares from equity incentive lock-up [2] - **Loxin Medical (300562)**: 110,000 shares from equity incentive lock-up [2] - **Bona Film (001330)**: 319 million shares from pre-issue lock-up [2] - **Yuanfei Pet (001222)**: 112 million shares from pre-issue lock-up [2] - **Kaige Precision Machinery (301338)**: 72.1 million shares from pre-issue lock-up [2] - **Dingjide (603255)**: 72.7914 million shares from pre-issue lock-up [2] - **Shangji Technology (301330)**: 18.515 million shares from pre-issue lock-up [2] - **Zhongchumai (688267)**: 83.3928 million shares [2] - **Luwei Optoelectronics (688401)**: 77.6214 million shares [2] - **Haohan Depth (688292)**: 10.8085 million shares [2] - **Huicheng Co. (688403)**: 259 million shares [2] - **Kaiweite (688693)**: 921,100 shares [2] - **Xinyu Ren (688573)**: 122,190 shares [2] - **Sinan Navigation (688592)**: 77,700 shares [2]

Group 1 - The latest LPR values for 1-year and 5-year loans will be announced on August 20, with the current rates at 3.0% and 3.5% respectively, unchanged from June [2] - A total of 711.8 billion yuan in reverse repos will mature next week, with specific maturities scheduled from Monday to Friday [3] - The Hang Seng Index Company will announce the results of the second quarter index review on August 22, with changes effective from September 8, 2025 [4] Group 2 - The Jackson Hole Global Central Bank Conference will take place from August 21 to 23, featuring a speech by Federal Reserve Chairman Jerome Powell on August 22 [5] - The Federal Reserve will release the minutes of its monetary policy meeting on August 21, amid a pause in interest rate cuts since early this year, with current rates between 4.25% and 4.5% [6] - Nearly 100 billion yuan in market value of restricted stocks will be unlocked next week, with 35 stocks facing unlocks, including 29.54 billion yuan from United Imaging Healthcare [7][8] Group 3 - One new stock, Balanshi, is set to be issued next week on August 19, with approximately 19 million shares expected to raise nearly 300 million yuan [11]

Group 1 - The company held its third board meeting on August 11, 2025, where all seven directors attended, and the meeting complied with legal and regulatory requirements [2][4]. - The board approved the adjustment of the 2025 restricted stock incentive plan, reducing the number of initial grantees from 62 to 53 due to voluntary withdrawals, while maintaining the total number of shares at 2,009,540 [3][25]. - The board also approved the first grant of restricted stock to the 53 eligible grantees at a price of 9.63 yuan per share, with the grant date set for August 11, 2025 [5][32]. Group 2 - The company decided to postpone the completion date of the "Research and Development Center Construction Project" to December 31, 2026, due to delays in implementation and adjustments in project planning [7][14]. - The board believes that this postponement will enhance the efficiency of fund utilization and align with the company's long-term development needs [7][16]. - The postponement does not require shareholder approval as it falls within the board's authority [7][16]. Group 3 - The company raised a total of 467.51 million yuan from its initial public offering in August 2022, with a net amount of 408.71 million yuan after deducting issuance costs [13]. - As of July 31, 2025, the company has invested 131.28 million yuan in its fundraising projects, with the total commitment amounting to 171.27 million yuan [13][14]. - The company has established a dedicated account for the management of raised funds, ensuring compliance with regulatory requirements [13].

证券日报网讯 8月12日晚间，源飞宠物发布公告称，公司第三届董事会第六次会议审议通过了《关于调 整2025年限制性股票激励计划授予激励对象名单的议案》等多项议案。 （文章来源：证券日报） ...

Core Viewpoint - The company has announced a delay in the expected completion date of its fundraising project related to the construction of a research and development center, extending it from August 17, 2025, to December 31, 2026 [2] Group 1 - The third meeting of the third board of directors will be held on August 11, 2025, to review the proposal for the delay of the fundraising project [2] - The delay does not change the implementation subject, method, or purpose of the fundraising project [2] - The delay is not expected to have a substantial impact on the implementation of the fundraising project [2]

Group 1 - The core point of the article is that Yuanfei Pet (SZ 001222) announced the convening of its third board meeting on August 11, 2025, to discuss adjustments to the 2025 restricted stock incentive plan [1] - For the year 2024, Yuanfei Pet's revenue composition is entirely from the pet sector, with a 100.0% contribution [1] - As of the report date, Yuanfei Pet has a market capitalization of 4 billion yuan [1]

Core Viewpoint - The company has decided to postpone the expected operational status date for the "Research and Development Center Construction Project" due to various factors affecting the project's execution timeline, ensuring that the quality of the investment is maintained and aligning with the company's long-term strategic goals [1][4]. Fundraising Project Situation - The company raised a total of RMB 467.51 million through the issuance of 34.1 million shares at a price of RMB 13.71 per share, with a net amount of RMB 408.71 million after deducting issuance costs [1]. - As of July 31, 2025, the company has allocated RMB 41.80 million to various projects, with a remaining balance of RMB 1.61 million [2][3]. Delay of Fundraising Projects - The expected operational status date for the "Research and Development Center Construction Project" has been postponed to December 31, 2026, due to delays in construction and approval processes [3][4]. - The delay is attributed to the project's location within the same building as another project, which has affected the overall timeline [3]. Impact of Delay - The postponement of the fundraising projects is deemed a prudent decision that will not adversely affect the company's operations or shareholder interests, and it complies with relevant regulations [4][5]. - The company aims to enhance the efficiency of fundraising usage and strengthen its ongoing operational capabilities through this adjustment [4]. Review Procedures and Opinions - The board of directors has approved the delay, considering it beneficial for the company's long-term development and in line with regulatory requirements [4][5]. - The sponsoring institution has confirmed that the decision followed necessary procedures and aligns with the company's business development plans [5].

北京植德律师事务所 关于 温州源飞宠物玩具制品股份有限公司 激励权益调整暨首次授予事项的 法律意见书 植德（证）字[2025]0038 号 二〇二五年八月 北京植德律师事务所 Merits & Tree Law Offices 北京市东城区东直门南大街 1 号来福士中心办公楼 12 层 邮编：100007 Dongcheng District, Beijing 100007 P.R.C 电话(Tel)：010-56500900 传真(Fax)：010-56500999 www.meritsandtree.com 北京植德律师事务所 关于温州源飞宠物玩具制品股份有限公司 激励权益调整暨首次授予事项的 法律意见书 植德（证）字[2025]0038 号 致：温州源飞宠物玩具制品股份有限公司 根据本所与公司签署的《律师服务协议书》，本所接受公司的委托，担任公 司本次股权激励的专项法律顾问，并已出具了《北京植德律师事务所关于温州源 飞宠物玩具制品股份有限公司 2025 年限制性股票激励计划的法律意见书》（以 下称"《股权激励法律意见书》"）。 根据《公司法》《证券法》《管理办法》《上市规则》《业务办理指南》及 其它相关 ...

证券代码：001222 证券简称：源飞宠物 公告编号：2025-036 一、激励计划简述及已履行的审批程序 （一）本激励计划简述 温州源飞宠物玩具制品股份有限公司 关于向 2025 年限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 温州源飞宠物玩具制品股份有限公司（以下简称"公司"）于 2025 年 8 月 11 日召开了第三届董事会第六次会议，审议通过了《关于调整 2025 年限制性股票 激励计划授予激励对象名单的议案》、《关于向 2025 年限制性股票激励计划激 励对象首次授予限制性股票的议案》。公司董事会认为《温州源飞宠物玩具制品 股份有限公司 2025 年限制性股票激励计划（草案）》 （以下简称"本激励计划"、 "本次激励计划"或"《激励计划（草案）》"）规定的限制性股票授予条件业 已成就，根据公司 2025 年第一次临时股东会的授权情况，确定以 2025 年 8 月 11 日为首次授予的授予日，向符合条件的 53 名首次授予激励对象授予 200.9540 万 股限制性股票。现对有关 ...

证券代码：001222 证券简称：源飞宠物 公告编号：2025-035 上述具体内容详见公司分别于 2025 年 7 月 22 日、8 月 6 日、8 月 12 日、8 月 13 日在巨潮资讯网（www.cninfo.com.cn）等指定信息披露媒体上披露的相关 公告及文件。 二、调整事项具体情况 温州源飞宠物玩具制品股份有限公司 关于调整 2025 年限制性股票激励计划授予激励对象名单的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 温州源飞宠物玩具制品股份有限公司（以下简称"公司"）于 2025 年 8 月 11 日召开第三届董事会第六次会议，审议通过了《关于调整 2025 年限制性股票激 励计划授予激励对象名单的议案》，具体情况如下： 一、股权激励计划已履行的程序 于<2025 年限制性股票激励计划（草案）>及其摘要的议案》、《关于<2025 年限 制性股票激励计划实施考核管理办法>的议案》等议案。前述相关议案已经公司 第三届董事会薪酬与考核委员会 2025 年第二次会议审议通过，董事会薪酬与考 核委员会发表明确同意的核查意见。北京植德律师事务所出 ...